PAREKH RAJESH B 4
4 · Eloxx Pharmaceuticals, Inc. · Filed Jun 17, 2022
Insider Transaction Report
Form 4
PAREKH RAJESH R
Director
Transactions
- Award
Stock Options (Right to Buy)
2022-06-15+20,000→ 20,000 totalExercise: $0.26Exp: 2032-06-15→ Common Stock (20,000 underlying)
Footnotes (2)
- [F1]The stock option vests as to 50% of the underlying shares on June 15, 2023 and the remainder in twelve (12) equal monthly installments thereafter.
- [F2]The Reporting Person will assign the economic interests of this grant to Advent Life Sciences LLP. The Reporting Person is a general partner of Advent Life Sciences LLP.